Expertise in
30
conditions

Dr. Aaron R. Alizadeh

Internal Medicine
Valley View Hospital
1906 Blake Ave, 
Glenwood Springs, CO 
Accepting New Patients
Offers Telehealth
Expertise in
30
conditions
Valley View Hospital
1906 Blake Ave, 
Glenwood Springs, CO 

Overview

Aaron Alizadeh is a primary care provider, practicing in Internal Medicine in Glenwood Springs, Colorado.

Dr. Alizadeh is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Multiple Myeloma, Anemia, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 5 clinical trials. Dr. Alizadeh is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in GA

Hospital Affiliations

Aspen Valley Hospital District
Grand River Hospital District
Northside Hospital
Emory Decatur Hospital
Valley View Hospital Association

Languages Spoken

English
German
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Valley View Hospital
1906 Blake Ave, Glenwood Springs, CO 81601
Other Locations
Georgia Cancer Specialists I PC
2712 Lawrenceville Hwy, Decatur, GA 30033

Additional Areas of Focus

Dr. Alizadeh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab, Sargramostim
Study Phase: Phase 2/Phase 3
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological
Study Drugs: Ipilimumab, Pembrolizumab, Recombinant Interferon Alfa-2b
Study Phase: Phase 3
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 2 Study of Glembatumumab Vedotin, an Anti-gpNMB Antibody-drug Conjugate, as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma
A Phase 2 Study of Glembatumumab Vedotin, an Anti-gpNMB Antibody-drug Conjugate, as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma
Enrollment Status: Terminated
Publish Date: September 06, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

1 Total Publications

A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Journal: Cancer
Published: June 05, 2018
Similar Doctors
Expertise in
20
conditions
Dr. David J. Borchers
Internal Medicine
Expertise in
20
conditions
Dr. David J. Borchers
Internal Medicine

MDVIP - Basalt, CO

100 Elk Run Dr Ste 101, 
Basalt, CO 
 (19.6 miles away)
970-430-4936
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Borchers is a primary care provider, practicing in Internal Medicine in Basalt, Colorado. Dr. Borchers is highly rated in 20 conditions, according to our data. His clinical expertise encompasses High Cholesterol, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Cirrhosis, and Chronic Cough.

Expertise in
27
conditions
Dr. Edward A. Wiese
Internal Medicine
Expertise in
27
conditions
Dr. Edward A. Wiese
Internal Medicine

Aspen Valley Hospital

401 Castle Creek Rd, 
Aspen, CO 
 (34.9 miles away)
970-925-1120
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Edward Wiese is a primary care provider, practicing in Internal Medicine in Aspen, Colorado. Dr. Wiese is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Pulmonary Fibrosis. Dr. Wiese is currently accepting new patients.

Expertise in
14
conditions
Dr. Bryan C. Gieszl
Internal Medicine
Expertise in
14
conditions
Dr. Bryan C. Gieszl
Internal Medicine
Before you request

Office

204 Basalt Center Cir, 
Basalt, CO 
 (19.1 miles away)
970-927-3141
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bryan Gieszl is a primary care provider, practicing in Internal Medicine in Basalt, Colorado. Dr. Gieszl is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Insomnia, Gout, Cellulitis, and Hypothyroidism. Dr. Gieszl is currently accepting new patients.

Frequently Asked Questions about Dr. Aaron R. Alizadeh

How do I make an appointment with Dr. Aaron R. Alizadeh?

You can book an appointment with Dr. Aaron R. Alizadeh by calling their office at 970-384-6874. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Aaron R. Alizadeh a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Aaron R. Alizadeh is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Aaron R. Alizadeh specialize in?

While Dr. Aaron R. Alizadeh is a Internal Medicine, they have specific expertise in Familial Colorectal Cancer, Colorectal Cancer, and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Aaron R. Alizadeh participate in research or clinical trials?

Yes. Dr. Aaron R. Alizadeh has published 1 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Aaron R. Alizadeh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Aaron R. Alizadeh accept my insurance?

Dr. Aaron R. Alizadeh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 970-384-6874 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alizadeh's expertise for a condition
ConditionClose
    View All 27 Advanced Conditions
    View All 165 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile